BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE

What it is

BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as butalbital, aspirin, and caffeine.

FDA gives its dosage form as capsule and its route as oral.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Lannett Company, Inc., Sandoz Inc and Chartwell RX, LLC.

FDA lists it under 5 Established Pharmacologic Classes: Barbiturate, Central Nervous System Stimulant, Methylxanthine, Nonsteroidal Anti-inflammatory Drug and Platelet Aggregation Inhibitor.

The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $28.45 for 30 capsules (30 × $0.94823 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

What NADAC measures · Why 30 capsules · NADAC explanation codes

All 4 NDCs

• 00527-1552-01 · Lannett Company, Inc. · $0.94823 per EA · eff. 2026-09-23 filed
• 00781-2270-01 · Sandoz Inc · $0.94823 per EA · eff. 2026-09-23 filed
• 62135-0433-90 · Chartwell RX, LLC · $0.94823 per EA · eff. 2026-09-23 filed
• 69367-0416-01 · Westminster Pharmaceuticals, LLC · $0.94823 per EA · eff. 2026-09-23 filed

Compared with its class

The middle of its 4 NDCs’ NADAC prices is $0.94823 per EA filed.

Of the 10 other products in FDA’s Barbiturate class priced per EA, 5 have a higher middle NADAC price and 5 a lower one. The one in the middle is BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB, at $0.87462 per EA filed (eff. 2026-09-23).

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 151 have a higher middle NADAC price and 52 a lower one. The one in the middle is FOCALIN XR 5 MG CAPSULE, at $4.70352 per EA filed (eff. 2026-09-23).

Of the 32 other products in FDA’s Methylxanthine class priced per EA, 12 have a higher middle NADAC price and 20 a lower one. The one in the middle is QC STAY AWAKE 200 MG TABLET, at $0.08299 per EA filed (eff. 2026-09-23).

Of the 154 other products in FDA’s Nonsteroidal Anti-inflammatory Drug class priced per EA, 31 have a higher middle NADAC price and 123 a lower one. The one in the middle is INDOMETHACIN 25 MG CAPSULE, at $0.09341 per EA filed (eff. 2026-09-23).

Of the 35 other products in FDA’s Platelet Aggregation Inhibitor class priced per EA, 2 have a higher middle NADAC price and 33 a lower one. The one in the middle is SM ASPIRIN 81 MG CHEWABLE TAB, at $0.02571 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $25.87 for 30 capsules, at an average of $0.86237 per EA in 2024 (2024-01-01 to 2024-12-31) for “Butalbital-Aspirin-Caffeine” and “Butalbital/Aspirin/Caffeine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 44,947 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.